Cohort Study: Modelling Toxicity Processing in Patients Treated by Immunotherapy (MOTIVATE).
NCT03447483
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumor
Interventions
OTHER:
Patients starting a treatment by ICI
Sponsor
Institut Claudius Regaud